Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Project Grant

University of Toronto

$749,700.00

Viral innate immunity in S. cerevisiae

EF 2022-23

Résumé
Viruses infect all known forms of life, including single celled organisms such as bacteria and yeasts. While studies of viruses in bacteria have led to remarkable advances for basic research such as the discovery of CRISPR, single-celled eukaryotic organisms have been comparatively silent on this topic. We have discovered a new anti-viral mechanism in the budding yeast Saccharomyces cerevisiae. This mechanism employs a protein called Nuc1, which is homologous to endonuclease G (endoG), a protein family found in all eukaryotic organisms, and even in bacteria. Nuc1, like endoG, resides within the cells mitochondria, a known hub of viral innate immunity in humans. Through our studies of Nuc1, we have discovered that the yeast "L-A" virus causes lethal pathogenesis when it is left unchecked in cells lacking Nuc1. We have exploited this lethal consequence of the L-A virus to discover new factors controlling viral repression. Intriguingly, human homologs of some of these factors attenuate SARS-Cov-2, though their mechanism remains unknown. This work exploits the unparalleled power of yeast as an experimental model to investigate these new viral repression mechanisms.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
469976
Name
Meneghini Marc D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Biochemistry & Molecular Biology - B
Projecttitle
Viral innate immunity in S. cerevisiae
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$749,700
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Dsrna Virus; Innate Immunity; Mitochondria; Proteostasis; Saga Complex; Yeast
Abstract
Viruses infect all known forms of life, including single celled organisms such as bacteria and yeasts. While studies of viruses in bacteria have led to remarkable advances for basic research such as the discovery of CRISPR, single-celled eukaryotic organisms have been comparatively silent on this topic. We have discovered a new anti-viral mechanism in the budding yeast Saccharomyces cerevisiae. This mechanism employs a protein called Nuc1, which is homologous to endonuclease G (endoG), a protein family found in all eukaryotic organisms, and even in bacteria. Nuc1, like endoG, resides within the cells mitochondria, a known hub of viral innate immunity in humans. Through our studies of Nuc1, we have discovered that the yeast "L-A" virus causes lethal pathogenesis when it is left unchecked in cells lacking Nuc1. We have exploited this lethal consequence of the L-A virus to discover new factors controlling viral repression. Intriguingly, human homologs of some of these factors attenuate SARS-Cov-2, though their mechanism remains unknown. This work exploits the unparalleled power of yeast as an experimental model to investigate these new viral repression mechanisms.
Competitiondate
202209
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Meneghini, Marc D
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $749,700~ $0~